Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
47.56
+1.69 (3.68%)
At close: Jan 17, 2025, 4:00 PM
47.46
-0.10 (-0.21%)
After-hours: Jan 17, 2025, 6:01 PM EST

Twist Bioscience Revenue

In the fiscal year ending September 30, 2024, Twist Bioscience had annual revenue of $312.97M with 27.69% growth. Twist Bioscience had revenue of $84.71M in the quarter ending September 30, 2024, with 26.53% growth.

Revenue (ttm)
$312.97M
Revenue Growth
+27.69%
P/S Ratio
8.82
Revenue / Employee
$339,083
Employees
923
Market Cap
2.83B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024312.97M67.87M27.69%
Sep 30, 2023245.11M41.54M20.41%
Sep 30, 2022203.57M71.23M53.83%
Sep 30, 2021132.33M42.23M46.87%
Sep 30, 202090.10M35.72M65.67%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings